全球布魯氏菌病疫苗市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

全球布魯氏菌病疫苗市場需求預計將從 2023 年的 27,938 萬美元達到 2032 年近 4,4,128 萬美元的市場規模，2024-2032 年研究期間複合年成長率為 5.21%。

布魯氏菌病也稱為馬耳他熱、波浪熱、地中海熱，是由受感染動物的未煮熟的肉或攝入未經高溫消毒的牛奶或與其分泌物密切接觸而引起的感染。布魯氏菌病疫苗適用於牛、綿羊和山羊。目前，尚無適用於人類的疫苗。疫苗接種的作用是產生免疫反應，增強動物對疾病的抵抗力，對於控制、管理和消除布魯氏菌病很重要。

市場動態

畜牧業生產的成長和動物傳播傳染病的威脅正在推動市場的成長。隨著畜牧業的持續成長和轉型，糧食安全和人類營養面臨巨大的挑戰。受牛奶、肉類和雞蛋消費量增加的影響，對畜產品的需求日益成長。在全球範圍內，布魯氏菌病被認為是最常見的人畜共通傳染病，每年記錄的病例超過 50 萬例。市場的成長得到了疫苗接種計劃的支持。另一方面，許多地區無法提供有效的診斷或治療，或沒有充分執行檢測和預防人類和動物感染的計畫。這些地區需要政府獸醫和衛生部門之間的協調與合作，以幫助預防和控制布魯氏菌病。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球布魯氏菌病疫苗市場的每個細分市場進行了包容性評估。布魯氏菌病疫苗產業的成長和趨勢為本研究提供了整體方法。

市場區隔

布魯氏菌病疫苗市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按類型

• 次單位疫苗（重組疫苗、結合疫苗、類毒素疫苗）
• 去活化
• 活衰減
• mRNA腺病毒
• 病毒載體疫苗

依給藥途徑

• 口服
• 注射用
• 鼻腔

按疾病適應症

• 病毒性疾病（肝炎、流感、HPV、MMR、輪狀病毒、帶狀皰疹、Covid-19 等）
• 細菌疫苗（腦膜炎雙球菌病、肺炎球菌病、百白破、其他）
• 癌症疫苗
• 過敏疫苗

按年齡

• 兒科
• 成人

按配銷通路

• 醫院和零售藥房
• 政府供應商
• 其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲布魯氏菌病疫苗市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。布魯氏菌病疫苗市場的主要參與者包括 Merck & Co. Inc.、Laboratories Tornel、Hester Biosciences Limited、Ceva、CZ Vaccines。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

• 報告說明
  • 客觀的
  • 目標受眾
  • 獨特的銷售主張 (USP) 和產品
• 研究範圍
• 研究方法
  • 市場研究過程
  • 市場研究方法論

第 2 章：執行摘要

• 市場亮點
• 全球市場概況

第 3 章：布魯氏菌病疫苗 - 產業分析

• 簡介 - 市場動態
• 市場促進因素
• 市場限制
• 機會
• 產業動態
• 波特五力分析
• 市場吸引力分析
  • 按類型分類的市場吸引力分析
  • 按給藥途徑進行的市場吸引力分析
  • 依疾病適應症進行的市場吸引力分析
  • 按年齡分類的市場吸引力分析
  • 按配銷通路分類的市場吸引力分析
  • 市場吸引力分析：按地區

第 4 章：價值鏈分析

• 價值鏈分析
• 原料分析
  • 原料清單
  • 原料廠商清單
  • 主要原物料價格走勢
• 潛在買家名單
• 行銷管道
  • 直效行銷
  • 間接行銷
  • 行銷通路發展趨勢

第 5 章：全球布魯氏菌病疫苗市場分析：按類型

• 按類型概述
• 按類型分析歷史和預測數據
• 次單位疫苗（重組疫苗、結合疫苗、類毒素疫苗）
• 去活化
• 活衰減
• mRNA腺病毒
• 病毒載體疫苗

第 6 章：全球布魯氏菌病疫苗市場分析：依給藥途徑

• 依給藥途徑概述
• 按給藥途徑進行歷史和預測資料分析
• 口服
• 注射用
• 鼻腔

第 7 章：全球布魯氏菌病疫苗市場分析：依疾病適應症

• 按疾病適應症概述
• 按疾病跡象進行歷史和預測數據分析
• 病毒性疾病（肝炎、流感、HPV、MMR、輪狀病毒、帶狀皰疹、Covid-19 等）
• 細菌疫苗（腦膜炎雙球菌病、肺炎球菌病、百白破、其他）
• 癌症疫苗
• 過敏疫苗

第 8 章：全球布魯氏菌病疫苗市場分析：依年齡分類

• 按年齡分類概述
• 按年齡分類的歷史和預測資料分析
• 兒科
• 成人

第 9 章：全球布魯氏菌病疫苗市場分析：按分銷管道

• 配銷通路概覽
• 按配銷通路進行歷史和預測資料分析
• 醫院和零售藥房
• 政府供應商
• 其他

第 10 章：全球布魯氏菌病疫苗市場分析：依地理位置

• 區域展望
• 介紹
• 北美銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 北美按細分市場銷售分析
  • 北美按國家銷售分析
  • 美國銷售分析
  • 加拿大銷售分析
  • 墨西哥銷售分析
• 歐洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 歐洲按細分市場銷售分析
  • 歐洲按國家銷售分析
  • 英國銷售分析
  • 法國銷售分析
  • 德國銷售分析
  • 義大利銷售分析
  • 俄羅斯銷售分析
  • 歐洲其他地區銷售分析
• 亞太地區銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 亞太地區按細分市場銷售分析
  • 亞太地區按國家銷售分析
  • 中國銷售分析
  • 印度銷售分析
  • 日本銷售分析
  • 韓國銷售分析
  • 澳洲銷售分析
  • 東南亞銷售分析
  • 亞太地區其他地區銷售分析
• 拉丁美洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 拉丁美洲按細分市場銷售分析
  • 拉丁美洲按國家銷售分析
  • 巴西銷售分析
  • 阿根廷銷售分析
  • 秘魯銷售分析
  • 智利銷售分析
  • 拉丁美洲其他地區銷售分析
• 中東和非洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 中東和非洲按細分市場銷售分析
  • 中東和非洲按國家銷售分析
  • 沙烏地阿拉伯銷售分析
  • 阿拉伯聯合大公國銷售分析
  • 以色列銷售分析
  • 南非銷售分析
  • 中東其他地區和非洲銷售分析

第 11 章：布魯氏菌病疫苗公司的競爭格局

• 布魯氏菌病疫苗市場競爭
• 夥伴關係/協作/協議
• 併購
• 新產品發布
• 其他發展

第 12 章：公司簡介

• 頂級公司市佔率分析
• 市場集中度
• Merck & Co. Inc.
• 公司概況
• 公司收入
• 產品
• 最新動態
• Laboratories Tornel
• 公司概況
• 公司收入
• 產品
• 最新動態
• Hester Biosciences Limited
• 公司概況
• 公司收入
• 產品
• 最新動態
• Ceva
• 公司概況
• 公司收入
• 產品
• 最新動態
• CZ Vaccines
• 公司概況
• 公司收入
• 產品
• 最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

The global demand for Brucellosis Vaccines Market is presumed to reach the market size of nearly USD 441.28 Million by 2032 from USD 279.38 Million in 2023 with a CAGR of 5.21% under the study period 2024-2032.

Brucellosis also is known as malta fever, undulant fever, Mediterranean fever, is an infection caused by undercooked meat of infected animals or ingestion of unpasteurized milk or close contact with their secretion. Brucellosis vaccine is meant for cattle, sheep and goats. Currently, there is no vaccine available for humans. Vaccination works by producing an immune response that increases the animal's resistance to the diseases and is important to control, manage and eliminate brucellosis.

MARKET DYNAMICS

Growing livestock production and the threat of animal-borne infectious diseases are driving the growth of the market. With continuous growth and transformation of the livestock sector offer substantial challenges associated with food security and human nutrition. Demand for livestock products is growing influenced by increasing consumption of milk, meat, and eggs. Globally, brucellosis is considered as the most common zoonotic disease, with more than 500,000 cases recorded annually. Growth of the market is backed by a vaccination programme. On the other hand, there are many regions where effective diagnosis or treatment is not available or where programmes for the detection and prevention of the infection in humans and animals are not adequately carried out. Such regions need co-ordination and collaboration between veterinary and health sectors of government to help prevent and control brucellosis.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Brucellosis Vaccines. The growth and trends of Brucellosis Vaccines industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Brucellosis Vaccines market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

• Subunit Vaccines (Recombinant Vaccines, Conjugate Vaccines, Toxoid Vaccines)
• Inactivated
• Live Attenuated
• mRNA Aaccines
• Viral Vector Vaccines

By Route of Administration

• Oral
• Parenteral
• Nasal

By Disease Indication

• Viral Diseases (Hepatitis, Influenza, HPV, MMR, Rotavirus, Herpes Zoster, Covid-19, Others)
• Bacterial Vaccines (Meningococcal Diseases, Pneumococcal Diseases, DPT, Others)
• Cancer Vaccines
• Allergy Vaccines

By Age

• Pediatric
• Adult

By Distribution Channel

• Hospital & Retail Pharmacies
• Government Suppliers
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Brucellosis Vaccines market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Brucellosis Vaccines market include Merck & Co. Inc., Laboratories Tornel, Hester Biosciences Limited, Ceva, CZ Vaccines. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. BRUCELLOSIS VACCINES - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Type
  • 3.7.2 Market Attractiveness Analysis By Route of Administration
  • 3.7.3 Market Attractiveness Analysis By Disease Indication
  • 3.7.4 Market Attractiveness Analysis By Age
  • 3.7.5 Market Attractiveness Analysis By Distribution Channel
  • 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL BRUCELLOSIS VACCINES MARKET ANALYSIS BY TYPE

• 5.1. Overview By Type
• 5.2. Historical and Forecast Data Analysis By Type
• 5.3. Subunit Vaccines (Recombinant Vaccines, Conjugate Vaccines, Toxoid Vaccines) Historic and Forecast Sales By Regions
• 5.4. Inactivated Historic and Forecast Sales By Regions
• 5.5. Live Attenuated Historic and Forecast Sales By Regions
• 5.6. mRNA Aaccines Historic and Forecast Sales By Regions
• 5.7. Viral Vector Vaccines Historic and Forecast Sales By Regions

6. GLOBAL BRUCELLOSIS VACCINES MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

• 6.1. Overview By Route of Administration
• 6.2. Historical and Forecast Data Analysis By Route of Administration
• 6.3. Oral Historic and Forecast Sales By Regions
• 6.4. Parenteral Historic and Forecast Sales By Regions
• 6.5. Nasal Historic and Forecast Sales By Regions

7. GLOBAL BRUCELLOSIS VACCINES MARKET ANALYSIS BY DISEASE INDICATION

• 7.1. Overview By Disease Indication
• 7.2. Historical and Forecast Data Analysis By Disease Indication
• 7.3. Viral Diseases (Hepatitis, Influenza, HPV, MMR, Rotavirus, Herpes Zoster, Covid-19, Others) Historic and Forecast Sales By Regions
• 7.4. Bacterial Vaccines (Meningococcal Diseases, Pneumococcal Diseases, DPT, Others) Historic and Forecast Sales By Regions
• 7.5. Cancer Vaccines Historic and Forecast Sales By Regions
• 7.6. Allergy Vaccines Historic and Forecast Sales By Regions

8. GLOBAL BRUCELLOSIS VACCINES MARKET ANALYSIS BY AGE

• 8.1. Overview By Age
• 8.2. Historical and Forecast Data Analysis By Age
• 8.3. Pediatric Historic and Forecast Sales By Regions
• 8.4. Adult Historic and Forecast Sales By Regions

9. GLOBAL BRUCELLOSIS VACCINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

• 9.1. Overview By Distribution Channel
• 9.2. Historical and Forecast Data Analysis By Distribution Channel
• 9.3. Hospital & Retail Pharmacies Historic and Forecast Sales By Regions
• 9.4. Government Suppliers Historic and Forecast Sales By Regions
• 9.5. Others Historic and Forecast Sales By Regions

10. GLOBAL BRUCELLOSIS VACCINES MARKET ANALYSIS BY GEOGRAPHY

• 10.1. Regional Outlook
• 10.2. Introduction
• 10.3. North America Sales Analysis
  • 10.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 10.3.2 North America By Segment Sales Analysis
  • 10.3.3 North America By Country Sales Analysis
  • 10.3.4 United States Sales Analysis
  • 10.3.5 Canada Sales Analysis
  • 10.3.6 Mexico Sales Analysis
• 10.4. Europe Sales Analysis
  • 10.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 10.4.2 Europe By Segment Sales Analysis
  • 10.4.3 Europe By Country Sales Analysis
  • 10.4.4 United Kingdom Sales Analysis
  • 10.4.5 France Sales Analysis
  • 10.4.6 Germany Sales Analysis
  • 10.4.7 Italy Sales Analysis
  • 10.4.8 Russia Sales Analysis
  • 10.4.9 Rest Of Europe Sales Analysis
• 10.5. Asia Pacific Sales Analysis
  • 10.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 10.5.2 Asia Pacific By Segment Sales Analysis
  • 10.5.3 Asia Pacific By Country Sales Analysis
  • 10.5.4 China Sales Analysis
  • 10.5.5 India Sales Analysis
  • 10.5.6 Japan Sales Analysis
  • 10.5.7 South Korea Sales Analysis
  • 10.5.8 Australia Sales Analysis
  • 10.5.9 South East Asia Sales Analysis
  • 10.5.10 Rest Of Asia Pacific Sales Analysis
• 10.6. Latin America Sales Analysis
  • 10.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 10.6.2 Latin America By Segment Sales Analysis
  • 10.6.3 Latin America By Country Sales Analysis
  • 10.6.4 Brazil Sales Analysis
  • 10.6.5 Argentina Sales Analysis
  • 10.6.6 Peru Sales Analysis
  • 10.6.7 Chile Sales Analysis
  • 10.6.8 Rest of Latin America Sales Analysis
• 10.7. Middle East & Africa Sales Analysis
  • 10.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 10.7.2 Middle East & Africa By Segment Sales Analysis
  • 10.7.3 Middle East & Africa By Country Sales Analysis
  • 10.7.4 Saudi Arabia Sales Analysis
  • 10.7.5 UAE Sales Analysis
  • 10.7.6 Israel Sales Analysis
  • 10.7.7 South Africa Sales Analysis
  • 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE BRUCELLOSIS VACCINES COMPANIES

• 11.1. Brucellosis Vaccines Market Competition
• 11.2. Partnership/Collaboration/Agreement
• 11.3. Merger And Acquisitions
• 11.4. New Product Launch
• 11.5. Other Developments

12. COMPANY PROFILES OF BRUCELLOSIS VACCINES INDUSTRY

• 12.1. Top Companies Market Share Analysis
• 12.2. Market Concentration Rate
• 12.3. Merck & Co. Inc.
  • 12.3.1 Company Overview
  • 12.3.2 Company Revenue
  • 12.3.3 Products
  • 12.3.4 Recent Developments
• 12.4. Laboratories Tornel
  • 12.4.1 Company Overview
  • 12.4.2 Company Revenue
  • 12.4.3 Products
  • 12.4.4 Recent Developments
• 12.5. Hester Biosciences Limited
  • 12.5.1 Company Overview
  • 12.5.2 Company Revenue
  • 12.5.3 Products
  • 12.5.4 Recent Developments
• 12.6. Ceva
  • 12.6.1 Company Overview
  • 12.6.2 Company Revenue
  • 12.6.3 Products
  • 12.6.4 Recent Developments
• 12.7. CZ Vaccines
  • 12.7.1 Company Overview
  • 12.7.2 Company Revenue
  • 12.7.3 Products
  • 12.7.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Type (USD MN)
• Subunit Vaccines (Recombinant Vaccines, Conjugate Vaccines, Toxoid Vaccines) Market Sales By Geography (USD MN)
• Inactivated Market Sales By Geography (USD MN)
• Live Attenuated Market Sales By Geography (USD MN)
• mRNA Aaccines Market Sales By Geography (USD MN)
• Viral Vector Vaccines Market Sales By Geography (USD MN)
• Analysis By Route of Administration (USD MN)
• Oral Market Sales By Geography (USD MN)
• Parenteral Market Sales By Geography (USD MN)
• Nasal Market Sales By Geography (USD MN)
• Analysis By Disease Indication (USD MN)
• Viral Diseases (Hepatitis, Influenza, HPV, MMR, Rotavirus, Herpes Zoster, Covid-19, Others) Market Sales By Geography (USD MN)
• Bacterial Vaccines (Meningococcal Diseases, Pneumococcal Diseases, DPT, Others) Market Sales By Geography (USD MN)
• Cancer Vaccines Market Sales By Geography (USD MN)
• Allergy Vaccines Market Sales By Geography (USD MN)
• Analysis By Age (USD MN)
• Pediatric Market Sales By Geography (USD MN)
• Adult Market Sales By Geography (USD MN)
• Analysis By Distribution Channel (USD MN)
• Hospital & Retail Pharmacies Market Sales By Geography (USD MN)
• Government Suppliers Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Brucellosis Vaccines Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Brucellosis Vaccines Report
• Market Research Process
• Market Research Methodology
• Global Brucellosis Vaccines Market Size, By Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Type
• Market Attractiveness Analysis By Route of Administration
• Market Attractiveness Analysis By Disease Indication
• Market Attractiveness Analysis By Age
• Market Attractiveness Analysis By Distribution Channel
• Market Attractiveness Analysis By Region
• Value Chain Analysis
• Global Market Analysis By Type (USD MN)
• Subunit Vaccines (Recombinant Vaccines, Conjugate Vaccines, Toxoid Vaccines) Market Sales By Geography (USD MN)
• Inactivated Market Sales By Geography (USD MN)
• Live Attenuated Market Sales By Geography (USD MN)
• mRNA Aaccines Market Sales By Geography (USD MN)
• Viral Vector Vaccines Market Sales By Geography (USD MN)
• Global Market Analysis By Route of Administration (USD MN)
• Oral Market Sales By Geography (USD MN)
• Parenteral Market Sales By Geography (USD MN)
• Nasal Market Sales By Geography (USD MN)
• Global Market Analysis By Disease Indication (USD MN)
• Viral Diseases (Hepatitis, Influenza, HPV, MMR, Rotavirus, Herpes Zoster, Covid-19, Others) Market Sales By Geography (USD MN)
• Bacterial Vaccines (Meningococcal Diseases, Pneumococcal Diseases, DPT, Others) Market Sales By Geography (USD MN)
• Cancer Vaccines Market Sales By Geography (USD MN)
• Allergy Vaccines Market Sales By Geography (USD MN)
• Global Market Analysis By Age (USD MN)
• Pediatric Market Sales By Geography (USD MN)
• Adult Market Sales By Geography (USD MN)
• Global Market Analysis By Distribution Channel (USD MN)
• Hospital & Retail Pharmacies Market Sales By Geography (USD MN)
• Government Suppliers Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.